Alan Siroy

962 total citations
19 papers, 408 citations indexed

About

Alan Siroy is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Alan Siroy has authored 19 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Alan Siroy's work include Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (7 papers) and Cancer Genomics and Diagnostics (4 papers). Alan Siroy is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (7 papers) and Cancer Genomics and Diagnostics (4 papers). Alan Siroy collaborates with scholars based in United States, Ireland and Canada. Alan Siroy's co-authors include Jay Wasman, Michael T. Tetzlaff, Michael A. Davies, Alexander J. Lazar, Stephen Stone, Roland L. Bassett, Denái R. Milton, Jeffrey E. Gershenwald, Patrick Hwu and Russell R. Broaddus and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Alan Siroy

18 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Siroy United States 10 213 198 86 74 70 19 408
Aleksander Sekulic United States 8 221 1.0× 198 1.0× 37 0.4× 71 1.0× 46 0.7× 13 385
Jessica Esandrio United States 7 503 2.4× 171 0.9× 57 0.7× 116 1.6× 270 3.9× 10 640
Peter S. Zhang United States 10 167 0.8× 248 1.3× 64 0.7× 17 0.2× 145 2.1× 10 511
Deepti P. Wilks United Kingdom 8 149 0.7× 303 1.5× 19 0.2× 54 0.7× 25 0.4× 11 499
David W. Vredevoogd Netherlands 11 263 1.2× 227 1.1× 25 0.3× 36 0.5× 347 5.0× 17 604
Alex M C Yu Hong Kong 12 162 0.8× 136 0.7× 112 1.3× 40 0.5× 11 0.2× 17 432
Adrià Bernat‐Peguera Spain 8 163 0.8× 146 0.7× 15 0.2× 28 0.4× 46 0.7× 14 333
Ruoji Zhou United States 11 212 1.0× 254 1.3× 19 0.2× 54 0.7× 16 0.2× 28 483
Elena Menietti Switzerland 5 219 1.0× 174 0.9× 17 0.2× 23 0.3× 69 1.0× 7 357

Countries citing papers authored by Alan Siroy

Since Specialization
Citations

This map shows the geographic impact of Alan Siroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Siroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Siroy more than expected).

Fields of papers citing papers by Alan Siroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Siroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Siroy. The network helps show where Alan Siroy may publish in the future.

Co-authorship network of co-authors of Alan Siroy

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Siroy. A scholar is included among the top collaborators of Alan Siroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Siroy. Alan Siroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Siroy, Alan, et al.. (2020). Clinical and histopathologic features differentiating acute generalized exanthematous pustulosis and pustular psoriasis: A retrospective series. Journal of the American Academy of Dermatology. 83(1). 265–267. 10 indexed citations
2.
Patel, Vishal, et al.. (2020). Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions. Journal of Investigative Medicine High Impact Case Reports. 8. 2737405648–2737405648.
3.
Kimball, David, et al.. (2019). Novel diagnostic imaging features of facial lupus panniculitis: ultrasound, CT, and MR imaging with histopathology correlate. Clinical Imaging. 58. 177–181. 8 indexed citations
4.
Tetzlaff, Michael T., Denái R. Milton, Alan Siroy, et al.. (2019). Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers. 11(6). 754–754. 24 indexed citations
5.
Asirvatham, Jaya Ruth, et al.. (2019). Intravascular nevus cell aggregate in axillary lymph node mimicking metastatic breast carcinoma. The Breast Journal. 25(4). 726–727. 1 indexed citations
6.
Siroy, Alan, et al.. (2017). Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.. PubMed. 16(10). 1050–1052. 6 indexed citations
7.
Kim, Dae Won, Lauren E. Haydu, Aron Y. Joon, et al.. (2016). Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon‐V600 mutations in cutaneous melanoma patients. Cancer. 123(8). 1372–1381. 34 indexed citations
8.
Siroy, Alan, Phyu P. Aung, Carlos A. Torres‐Cabala, et al.. (2016). Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma. Human Pathology. 59. 48–54. 10 indexed citations
9.
Roszik, Jason, Chang‐Jiun Wu, Alan Siroy, et al.. (2016). Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression. Scientific Reports. 6(1). 19649–19649. 8 indexed citations
10.
Sholl, Lynette M., Aleodor A. Andea, Julia A. Bridge, et al.. (2015). Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Archives of Pathology & Laboratory Medicine. 140(4). 355–357. 9 indexed citations
11.
Roszik, Jason, Aron Y. Joon, Alan Siroy, et al.. (2015). A novel algorithm applicable to cancer next-generation sequencing panels to predict total tumor mutation load and correlation with clinical outcomes in melanoma.. Journal of Clinical Oncology. 33(15_suppl). 9071–9071. 1 indexed citations
12.
Davies, Michael A., Aron Y. Joon, Roland L. Bassett, et al.. (2015). Demographics, tumor characteristics, and clinical outcomes associated with somatic mutations in 201 cancer-related genes in advanced melanoma patients (pts).. Journal of Clinical Oncology. 33(15_suppl). 9057–9057. 1 indexed citations
13.
Stockman, David L., Jonathan L. Curry, Carlos A. Torres‐Cabala, et al.. (2015). Use of clinical next‐generation sequencing to identify melanomas harboring SMARCB1 mutations. Journal of Cutaneous Pathology. 42(5). 308–317. 11 indexed citations
14.
Bucheit, Amanda D., Guo Chen, Alan Siroy, et al.. (2014). Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAF V600 Mutations. Clinical Cancer Research. 20(21). 5527–5536. 109 indexed citations
15.
Kim, Daewon, Kunhwa Kim, Michael A. Davies, et al.. (2014). Clinical characteristics of patients with non-V600 BRAF mutant melanomas.. Journal of Clinical Oncology. 32(15_suppl). 9100–9100. 3 indexed citations
16.
Siroy, Alan, Fadi W. Abdul‐Karim, John D. Miedler, et al.. (2013). MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer. Human Pathology. 44(10). 2159–2166. 72 indexed citations
17.
Siroy, Alan & Jay Wasman. (2012). Metastatic Crohn Disease: A Rare Cutaneous Entity. Archives of Pathology & Laboratory Medicine. 136(3). 329–332. 45 indexed citations
18.
Siroy, Alan & Gregory T. MacLennan. (2011). Primary Melanoma of the Bladder. The Journal of Urology. 185(3). 1096–1097. 13 indexed citations
19.
Siroy, Alan, et al.. (2006). Acneiform eruptions associated with epidermal growth factor receptor–targeted chemotherapy. Journal of the American Academy of Dermatology. 56(3). 500–505. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026